← SynDRA
FOSDAGROCORAT
SynDRA canonical compound SYN0037848 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | NR3C1 |
| Mechanism of action | glucocorticoid receptor agonist |
| Indication | rheumatoid arthritis |
| Disease area | rheumatology |
All known targets
Mechanisms of action (all sources)
- NR3C1 MODULATOR
- NR3C1 AGONIST
Cross-references
Synonyms
- PF-04171327
- PF 04171327
- UNII-HPI19004QS
- HPI19004QS
- 2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-, (4bS,7R,8aR)-;2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-, (4bS,7R,8aR)-
- Fosdagrocorat [USAN:INN]
- Fosdagrocorat (USAN/INN)
- SCHEMBL1707427
- GTPL9649
- US8901310, Example 2
- CHEMBL3137316
- BDBM140010
- SB17317
- fosdagrocoratum
- RefChem:906138
- DTXCID601532242
- PF04171327
- Fosdagrocorat [USAN]
- FOSDAGROCORAT [INN]
- FOSDAGROCORAT [WHO-DD]
- orb1707301
- SCHEMBL29366860
- BVXLAHSJXXSWFF-KEKPKEOLSA-N
- GLXC-15764
- AKOS040741761
- DA-53385
- HY-16722
- CS-0012322
- NS00073322
- D10634
- G14501
- T15340
- dagrocorat 2-(dihydrogen phosphate)
- PF-4171327
Look up FOSDAGROCORAT in the interactive SynDRA portal →